UC San Diego joins NIAID-sponsored trial of Covid-19 booster vaccines
The COVAIL study will assess the safety and immunogenicity of additional doses of prototype and variant vaccines.
Covid-19
Latest in
Covid-19
Tonix’s application for Phase II Long Covid therapy trial cleared by FDA
The Phase II trial of TNX-102 is expected to start in the second quarter of this year.
Kintor’s proxalutamide lowers hospitalisation in Phase III Covid-19 trial
Proxalutamide treatment for more than seven days offered a 100% protection rate in trial subjects.
Akston to launch Phase II trial of Covid-19 booster vaccine in Netherlands
The trial will assess the immune system’s response to a 90µg booster dose of the AKS-452 vaccine in 600 subjects.
ARCA biopharma announces Phase IIb Covid-19 therapy trial data
In the trial, both the tested doses of rNAPc2 demonstrated to be well-tolerated.
Sorrento receives FDA clearance to start Phase II/III abivertinib trial in Covid-19
The multicentre trial with a Phase II run-in will be carried out at various centres in the US, Brazil and…
Covid-19 two years on: persistent symptoms of clinical trial disruption trouble certain therapy areas
In an exclusive analysis using GlobalData and ClinicalTrials.gov data, Clinical Trials Arena reveals which therapeutic areas are recuperating and which…
By
Adagio’s antibody meets primary endpoints in Phase II/III Covid-19 trials
In STAMP and EVADE trials, a 300mg dose of adintrevimab had a safety profile comparable to that of placebo.